The Danish government is putting pressure on the country’s DKr5.5tn (€737bn) pensions industry to invest more in the domestic ...
Novo Nordisk A/S (NYSE:NVO) is among the most profitable healthcare stocks to buy. On January 26, BMO Capital lifted the ...
There’s no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to ...
However, Novo Nordisk has a plan to get things back on track, and the company's oral Wegovy is part of that strategy. In ...
A play examining the meteoric rise of Danish weight-loss drug giant Novo Nordisk will premiere on Saturday at a theatre outside ...
A new play chronicling the meteoric ascent of Danish pharmaceutical giant Novo Nordisk is set to debut this Saturday at a ...
Thomas Rantzau, employee representative on the Board of Directors since 2018, has decided to pursue new opportunities outside Novo Nordisk A/S after 22 years of employment. Therefore, he steps down ...
Novo Nordisk A/S gains in GLP-1 obesity pills with strong U.S. marketing. Click for this NVO stock update and a preview of ...
The agreement, to gain rights to a portfolio of early-stage experimental obesity and diabetes drugs is the largest of its type in terms of total potential value.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results